tiprankstipranks
NovelStem International Corp (NSTM)
OTHER OTC:NSTM
US Market

NovelStem International (NSTM) Stock Price & Analysis

12 Followers

NSTM Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$0.06 - $0.30
Previous Close$0.07
Volume380.00
Average Volume (3M)6.13K
Market Cap
$2.81M
Enterprise Value$6.07M
Total Cash (Recent Filing)$6.96K
Total Debt (Recent Filing)$3.26M
Price to Earnings (P/E)-0.8
Beta0.12
Nov 14, 2022
EPS EstimateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.09
Shares Outstanding46,881,475
10 Day Avg. Volume438
30 Day Avg. Volume6,133
Standard Deviation0.30
R-Squared0.00076
Alpha0.02
Financial Highlights & Ratios
Price to Book (P/B)-1.40
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-9.70
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue289.00
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-1.45
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

Ownership Overview

49.56%0.00%0.05%50.39%
49.56%
Insiders
0.00%
Mutual Funds
0.05% Other Institutional Investors
50.39% Public Companies and
Individual Investors

Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

NSTM FAQ

What was NovelStem International Corp’s price range in the past 12 months?
NovelStem International Corp lowest stock price was $0.06 and its highest was $0.30 in the past 12 months.
    What is NovelStem International Corp’s market cap?
    Currently, no data Available
    When is NovelStem International Corp’s upcoming earnings report date?
    NovelStem International Corp’s upcoming earnings report date is Nov 14, 2022 which is 528 days ago.
      How were NovelStem International Corp’s earnings last quarter?
      Currently, no data Available
      Is NovelStem International Corp overvalued?
      According to Wall Street analysts NovelStem International Corp’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
        Does NovelStem International Corp pay dividends?
        NovelStem International Corp pays a Notavailable dividend of $0.45 which represents an annual dividend yield of N/A. See more information on NovelStem International Corp dividends here
          What is NovelStem International Corp’s EPS estimate?
          NovelStem International Corp’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does NovelStem International Corp have?
          NovelStem International Corp has 46,881,474 shares outstanding.
            What happened to NovelStem International Corp’s price movement after its last earnings report?
            Currently, no data Available
            Which hedge fund is a major shareholder of NovelStem International Corp?
            Currently, no hedge funds are holding shares in NSTM
            ---

            NovelStem International Stock Smart Score

            N/A
            Not Ranked
            1
            2
            3
            4
            5
            6
            7
            8
            9
            10

            Technicals

            SMA
            Negative
            20 days / 200 days
            Momentum
            -64.64%
            12-Months-Change

            Fundamentals

            Return on Equity
            Trailing 12-Months
            Asset Growth
            -1.38%
            Trailing 12-Months

            Company Description

            NovelStem International Corp

            NovelStem International Corp. developes novel diagnostic technology that can predict patients resistance to chemotherapy allowing for cancer treatments and the potential to reduce resistance to chemotherapy. The company was founded by Mitchell Rubenstein and Laurie S. Silvers on January 22, 1993 and is headquartered in Boca Raton, FL.
            ---
            Similar Stocks
            Company
            Price & Change
            Follow
            Adverum Biotechnologies
            Arrowhead Pharmaceuticals
            Crispr Therapeutics AG
            Pro-Dex
            Popular Stocks
            ---
            What's Included in PREMIUM?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis